Showing results (231-240 of 271) with videos related to

Sort By:
Pageof 28
Laryngoscope Investigative Otolaryngology|October 20, 2021
Early phase clinical studies of AR-42, a histone deacetylase inhibitor, for neurofibromatosis type 2-associated vestibular schwannomas and meningiomasD Bradley Welling, Katharine A Collier, Sarah S Burns, et al.
Journal of Neuro-Oncology|May 28, 2025
Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104Vihang Nakhate, Ina Ly, Alona Muzikansky, et al.
Molecular Cancer Therapeutics|May 5, 2022
A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath TumorsJuana Fernández-Rodríguez, Edgar Creus-Bachiller, Xiaohu Zhang, et al.
Neuro-Oncology|February 15, 2020
Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conferenceRoger J Packer, Antonio Iavarone, David T W Jones, et al.
Magnetic Resonance Imaging|June 15, 2023
CEST2022: Amide proton transfer-weighted MRI improves the diagnostic performance of multiparametric non-contrast-enhanced MRI techniques in patients with post-treatment high-grade gliomasQianqi Huang, Jingpu Wu, Nhat Le, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2018
Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic BiopsyShanshan Jiang, Charles G Eberhart, Michael Lim, et al.
Acta Neuropathologica Communications|August 30, 2019
Telomere alterations in neurofibromatosis type 1-associated solid tumorsFausto J Rodriguez, Mindy K Graham, Jacqueline A Brosnan-Cashman, et al.
Neuro-Oncology|April 28, 2023
Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromasAndrea M Gross, Eva Dombi, Pamela L Wolters, et al.
American Journal of Medical Genetics. Part A|April 25, 2017
The path forward: 2015 International Children's Tumor Foundation conference on neurofibromatosis type 1, type 2, and schwannomatosisJaishri O Blakeley, Annette Bakker, Anne Barker, et al.
Scientific Data|July 15, 2025
Integrated genomic analysis of NF1-associated peripheral nerve sheath tumors: an updated biorepository datasetJineta Banerjee, Yang Lyu, Stavriani C Makri, et al.
Pageof 28